[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Stem Cells Market Analysis by Therapy, Application and Geography - Trends and Forecast, 2015 - 2022

January 2016 | 125 pages | ID: G9B5574EC4AEN
Market Research Engine

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The global stem cells market is expected to grow at an incredible CAGR of 25.5% from 2015 to 2022 and reach a market value of US$297 billion by 2022. The emergence of Induced Pluripotent Stem (iPS) cells as an alternative to ESCs (embryonic stem cells), growth of developing markets, and evolution of new stem cell therapies represent promising growth opportunities for leading players in this sector.

Due to the increased funding from Government and Private sector and rising global awareness about stem cell therapies and research are the main factors which are driving this market. A surge in therapeutic research activities funded by governments across the world has immensely propelled the global stem cells market. However, the high cost of stem cell treatment and stringent government regulations against the harvesting of stem cells are expected to restrain the growth of the global stem cells market.

This report will definitely help you make well informed decisions related to the stem cell market.

The stem cell therapy market includes large number of players that are involved in development of stem cell therapies of the treatment of various diseases. Mesoblast Ltd. (Australia), Aastrom Biosciences, Inc. (U.S.), Celgene Corporation (U.S.), and StemCells, Inc. (U.S.) are the key players involved in the development of stem cell therapies across the globe.

Scope of the Report:

This market research report categorizes the stem cell therapy market into the following segments and sub-segments:

By Mode of Therapy
  • Allogeneic Stem Cell Therapy Market
    • CVS Diseases
    • CNS Diseases
    • GIT diseases
    • Eye Diseases
    • Musculoskeletal Disorders
    • Metabolic Diseases
    • Immune System Diseases
    • Wounds and Injuries
    • Others
  • Autologous Stem Cell Therapy Market
    • GIT Diseases
    • Musculoskeletal Disorders
    • CVS Diseases
    • CNS Diseases
    • Wounds and Injuries
    • Others
By Therapeutic Applications
  • Musculoskeletal Disorders
  • Metabolic Diseases
  • Immune System Diseases
  • GIT Diseases
  • Eye Diseases
  • CVS Diseases
  • CNS Diseases
  • Wounds and Injuries
  • Others
By Geography
  • North America
  • Europe
  • Asia-Pacific
  • RoW (Rest of the World)
CHAPTER 1 PREFACE

1.1 Report Description
1.2 Research Methodology

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 MARKET OVERVIEW

3.1 Market Trends and Future Outlook
  3.1.1 Global Stem Cells Market, 2010 – 2018 (USD Billion)
3.2 Market Dynamics
  3.2.1 Market Drivers
    3.2.1.1 Unmet Medical Needs
    3.2.1.2 Increasing Government Support
    3.2.1.3 Growing Medical Tourism
    3.2.1.4 Rising Stem Cells Banking Services
    3.2.1.5 Impact Analysis of the Market Drivers
  3.2.2 Market Restraints
    3.2.2.1 High Cost of Treatment
    3.2.2.2 Government Regulations against Unethical Harvesting of Stem Cells
    3.2.2.3 Impact Analysis of the Market Restraints
  3.2.3 Market Opportunities
    3.2.3.1 Rising Neurodegenerative Disease Patients
    3.2.3.2 Increasing Disposable Income in Emerging Nations
    3.2.3.3 Replacing Animal Tissue in Drug Discovery
    3.2.3.4 Growing Contract Research Industry
  3.2.4 Porter’s Five Forces Analysis for the Global Stem Cells Market
    3.2.4.1 Bargaining Power of Suppliers
    3.2.4.2 Bargaining Power of Buyers
    3.2.4.3 Threat of New Entrants
    3.2.4.4 Threat of Substitutes
  3.2.5 Competitive Rivalry
3.3 Market Attractiveness
  3.3.1 Market Attractiveness Analysis of the Global Stem Cells Market, By Geography

CHAPTER 4 GLOBAL STEM CELLS MARKET, BY PRODUCTS

4.1 Market Segmentation: Global Stem Cells Market, By Products
4.2 Overview
4.3 Adult Stem Cells Market, 2010 – 2018 (USD Billion)
  4.3.1 Hematopoietic Stem Cells Market, 2010 – 2018 (USD Billion)
  4.3.2 Mesenchymal Stem Cells Market, 2010 – 2018 (USD Billion)
  4.3.3 Neuronal Stem Cells Market, 2010 – 2018 (USD Billion)
  4.3.4 Dental Stem Cells (Mesenchymal Stem Cells, Neuronal Stem Cells) Market, 2010 – 2018 (USD Billion)
  4.3.5 Umbilical Cord Stem Cells (Hematopoietic Stem Cells, Mesenchymal Stem Cells) Market, 2010 – 2018 (USD Billion)
4.4 Human Embryonic Stem Cells Market, 2010 – 2018 (USD Billion)
4.5 Induced Pluripotent Stem Cells Market, 2010 – 2018 (USD Billion)
4.6 Rat Neural Stem Cells Market, 2010 – 2018 (USD Billion)
4.7 Very Small Embryonic-Like Stem Cells Market, 2010 – 2018 (USD Billion)

CHAPTER 5 GLOBAL STEM CELLS MARKET, BY TECHNOLOGY

5.1 Market Segmentation: Global Stem Cells Market, By Technology
5.2 Overview
5.3 Global Stem Cell Acquisition Market, 2010 – 2018 (USD Billion)
  5.3.1 Global Bone Marrow Harvest for Stem Cells, 2010 – 2018 (USD Billion)
  5.3.2 Global Apheresis for Stem Cells Market, 2010 – 2018 (USD Billion)
  5.3.3 Global Umbilical Cord Blood Market, 2010 – 2018 (USD Billion)
5.4 Global Stem Cell Production Market, 2010 – 2018 (USD Billion)
  5.4.1 Global Therapeutic Cloning for Stem Cells Market, 2010 – 2018 (USD Billion)
  5.4.2 Global Stem Cells Production By In Vitro Fertilization Market, 2010 – 2018 (USD Billion)
  5.4.3 Global Stem Cell Isolation Market, 2010 – 2018 (USD Billion)
  5.4.4 Global Stem Cell Culture Market, 2010 – 2018 (USD Billion)
5.5 Global Stem Cell Cryopreservation Market, 2010 – 2018 (USD Billion)
5.6 Global Stem Cells Expansion and Sub-Culture Market, 2010 – 2018 (USD Billion)

CHAPTER 6 GLOBAL STEM CELLS MARKET, BY APPLICATION

6.1 Market Segmentation: Global Stem Cells Market, By Application
6.2 Overview
6.3 Global Stem Cells Market in Regenerative Medicine, 2010 – 2018 (USD Billion)
  6.3.1 Stem Cells Market in Neurology, 2010 – 2018 (USD Billion)
  6.3.2 Global Stem Cells Market in Orthopedics, 2010 – 2018 (USD Billion)
  6.3.3 Global Stem Cells Market in Oncology, 2010 – 2018 (USD Billion)
  6.3.4 Global Stem Cells Market in Hematology, 2010 – 2018 (USD Billion)
  6.3.5 Global Stem Cells Market for Cardiovascular and Myocardial Infarction, 2010 – 2018 (USD Billion)
  6.3.6 Global Stem Cells Market for Injuries, 2010 – 2018 (USD Billion)
    6.3.6.1 Global Stem Cells Market for Wound Care, 2010 – 2018 (USD Billion)
    6.3.6.2 Global Stem Cells Market for Spinal Cord Injuries, 2010 – 2018 (USD Billion)
    6.3.6.3 Global Stem Cells Market for Other (Joint Injuries, Eye Injuries, Lacerations and Concussions) Injuries, 2010 – 2018 (USD Billion)
  6.3.7 Global Stem Cells Market for Diabetes, 2010 – 2018 (USD Billion)
  6.3.8 Global Stem Cells Market for Liver Disorders, 2010 – 2018 (USD Billion)
  6.3.9 Global Stem Cells Market for Incontinence, 2010 – 2018 (USD Billion)
  6.3.10 Global Stem Cells Market for Other (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder) Regenerative Medicine Applications, 2010 – 2018 (USD Billion)
6.4 Global Stem Cells Market in Drug Discovery and Development, 2010 – 2018 (USD Billion)

CHAPTER 7 GLOBAL STEM CELLS MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
  7.2.1 North America Stem Cells Market, 2010–2018 (USD Billion)
7.3 Europe
  7.3.1 Europe Stem Cells Market, 2010–2018 (USD Billion)
7.4 Asia
  7.4.1 Asia Stem Cells Market, 2010–2018 (USD Billion)
7.5 Rest of the World (Row)
  7.5.1 Row Stem Cells Market, 2010–2018 (USD Billion)

CHAPTER 8 COMPETITIVE LANDSCAPE

8.1 Heat Map Analysis for the Key Market Players
  8.1.1 Advanced Cell Technology Inc.
  8.1.2 STEMCELL Technologies Inc.
  8.1.3 Cellular Engineering Technologies Inc.
  8.1.4 Biotime Inc.
  8.1.5 Cellartis AB
8.2 Business Strategies for Success
  8.2.1 Focus on Research and Development
  8.2.2 Partnerships, Collaborations and Acquisitions

CHAPTER 9 COMPANY PROFILES

9.1 Advanced Cell Technology
  9.1.1 Company Overview
  9.1.2 Financial Overview
  9.1.3 Business Strategies
  9.1.4 Product Portfolio
  9.1.5 Recent Developments
9.2 Angel Biotechnology
  9.2.1 Company Overview
  9.2.2 Financial Overview
  9.2.3 Business Strategies
  9.2.4 Product Portfolio
  9.2.5 Recent Developments
9.3 Bioheart
  9.3.1 Company Overview
  9.3.2 Financial Overview
  9.3.3 Product Portfolio
  9.3.4 Business Strategies
  9.3.5 Recent Developments
9.4 Brainstorm Cell Therapeutics
  9.4.1 Company Overview
  9.4.2 Financial Overview
  9.4.3 Business Strategies
  9.4.4 Product Portfolio
  9.4.5 Recent Developments
9.5 California Stem Cell Inc.
  9.5.1 Company Overview
  9.5.2 Product Portfolio
  9.5.3 Business Strategies
  9.5.4 Recent Developments
9.6 Celgene Corporation Inc.
  9.6.1 Company Overview
  9.6.2 Financial Overview
  9.6.3 Business Strategies
  9.6.4 Product Portfolio
  9.6.5 Recent Developments
9.7 Cellartis AB
  9.7.1 Company Overview
  9.7.2 Business Strategies
  9.7.3 Product Portfolio
  9.7.4 Recent Developments
9.8 Cellular Engineering Technologies
  9.8.1 Company Overview
  9.8.2 Business Strategies
  9.8.3 Product Portfolio
  9.8.4 Recent Developments
9.9 Cytori Therapeutics Inc.
  9.9.1 Company Overview
  9.9.2 Financial Overview
  9.9.3 Product Portfolio
  9.9.4 Business Strategies
  9.9.5 Recent Developments
9.10 Biotime Inc.
  9.10.1 Company Overview
  9.10.2 Financial Overview
  9.10.3 Product Portfolio
  9.10.4 Business Strategies
  9.10.5 Recent Developments
Note: This TOC is just an overview. The points mentioned in this will change as per the clients market requirement.


More Publications